Why HER2+ cancer cells are dependent on high STARD3 expression remains unclear, but given its role in cholesterol traffic, it is postulated that STARD3 acts on HER2 cancer cells biology by modulating cholesterol homeostasis. This evidence concerns the gene ERBB2 and cancer.